Trials / Sponsors / Jubilant Therapeutics Inc.
Jubilant Therapeutics Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | 2022-04-08 |